FigureLabs

An AI agent that drafts scientific illustrations for researchers and publications.

Best for

Pick FigureLabs if you are a researcher or science communicator who wants to draft journal-style figures from a natural-language brief rather than assembling them by hand.

Skip if

Skip it if you need pixel-precise, citation-ready diagrams today or you already have a deep BioRender workflow and asset library you trust.

FigureLabs bills itself as the first AI agent purpose-built for scientific illustration, the kind of polished diagrams and figures that end up in journal papers, grant submissions, lab presentations, and textbooks. Instead of dropping you into a generic image generator, it positions itself as an agent that understands the conventions of scientific visuals: biological pathways, molecular structures, anatomical cutaways, experimental schematics, and the labelling norms that make a figure publishable rather than just pretty.

The obvious comparison is BioRender, which has owned this niche for years by selling a hand-built library of vector assets. FigureLabs is going at the same problem from the other direction, using a generative agent so users can describe a figure in natural language and have it composed rather than manually assembled. That makes it potentially attractive to researchers, science communicators, and educators who want faster iteration on complex visuals, though the tradeoff is the usual generative one: less template guarantees, more prompt iteration. Pricing and access details are not exposed on the marketing site at the time of writing.

Editor's take

An interesting agentic take on a niche BioRender has owned for years. The pitch is right and the problem is real, but the public site is thin enough that we'd treat this as one to watch and trial rather than commit a lab budget to until the capabilities and pricing are clearer.

— The AI Tool Bible editorial team

Pros

✅ Narrow focus on a real, painful workflow (scientific figure creation)
✅ Agentic approach means natural-language briefs instead of manual asset assembly
✅ Targets a domain where generic image models notoriously fail (labels, accuracy, conventions)

Cons

⚠️ Marketing site is sparse and reveals little about model, pricing, or capabilities
⚠️ Faces a well-entrenched competitor in BioRender with a large asset library
⚠️ Generative output may still need manual cleanup for journal-grade accuracy